Work

Mitigating the Impact of Covid-19 on Pharmacovigilance

Year: 2020

Type: editorial

Abstract: COVID-19 is changing the pharmacovigilance (PV) landscape.Traditionally, regulatory authorities used to follow well developed standard procedures to ensure safety of new products and had ample time to review the evidence.Low-and-middle-income countries (LMIC) are benefited from stringent reviews made by well-established regulatory systems in more advanced countries.

Source: Ethiopian Medical Journal

Authors: Abraham Aseffa, Sileshi Lulseged, Eysau Makonnen

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3091261074

Cites:

Cited by:

Related to: 10